Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials
Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients With Known or Suspected HIV Infection
2 other identifiers
observational
150
0 countries
N/A
Brief Summary
The purpose of this study is to monitor the progression of HIV infection and HIV-related disease processes in patients who have previously participated in HIV clinical trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Completion
Last participant's last visit for all outcomes
March 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedNovember 1, 2021
October 1, 2021
September 13, 2005
October 28, 2021
Conditions
Eligibility Criteria
HIV-infected individuals who have previously participated in NIAID-funded HIV clinical trials
You may qualify if:
- HIV infected
- Previously participated in a NIAID-funded clinical trial studying HIV disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Blood collection
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
JoAnn M. Mican, MD
Laboratory of Immunoregulation (LIR), NIAID
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 16, 2005
Study Completion
March 1, 2003
Last Updated
November 1, 2021
Record last verified: 2021-10